Adult respiratory distress syndrome: A disorder in need of improved outcome

Heart and Lung: Journal of Acute and Critical Care

Volumn 26, Issue 1, 1997, Pages 3-14

  Brandstetter, Robert D ^a   Sharma, Kailash C ^a   DellaBadia, Maryanne ^a   Cabreros, Lorie J ^a   Kabinoff, Gary S ^a  

^a New Rochelle Hospital Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIOXIDANT; CORTICOSTEROID; CYTOKINE; ICOSANOID; KETOCONAZOLE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTANOID; REACTIVE OXYGEN METABOLITE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANALGESIA; ASSISTED VENTILATION; EXTRACORPOREAL OXYGENATION; FLUID THERAPY; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG INJURY; MORTALITY; NUTRITION; PARALYSIS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEDATION; TREATMENT OUTCOME;

EID: 0031012858     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9563(97)90004-2     Document Type: Article

References (84)

1. Fishman AP, Gaensler EA, Swensen EW. Physiologists look at the problem. J Trauma 1968;8:924-9.
2. Fishman AP. Shock lung: a distinctive non-entity. Circulation 1973;47:921-3.
3. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory in adults. Lancet 1967;2:319-23.
4. Driscoll JM, Mellins RB. Idiopathic respiratory distress syndrome of infancy. Basics Respir Dis 1973;1:1-6.
5. Petty TL, Ashbaugh DG. The adult respiratory distress syndrome: clinical features, factors influencing prognosis and principles of management. Chest 1971;60:233-9.
6. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al., and the consensus committee. The American-European consensus conference on ARDS: definitions, mechanism, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
7. Demling RH. Adult respiratory distress syndrome: current concepts. Crit Care Med 1993;1:388-401.
8. Lamy M, Deby-Dupont G, Deby C, Faymonville M, Damas P. Why is our present therapy for adult respiratory distress syndrome so ineffective? Intensive Crit Care Dig 1992;11:6-12.
9. Brandstetter RD, Conetta R, Sander NW, Andresen AFR, Holstein SB. Adult respiratory distress syndrome in adolescents due to aspiration of gastric contents. NY State J Med 1986;86:513-6.
10. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-3.
11. Bone RC. Let's agree on terminology: definition of sepsis. Crit Care Med 1991;19:973-6.
12. Wiessner WH, Casey LC, Zbilut IP. Treatment of sepsis and septic shock: a review. Heart Lung 1995;24:380-92.
13. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
14. Bernard GR. Sepsis trials: intersection of investigation, regulation, funding and practice. Am J Respir Crit Care Med 1995;152:4-10.
15. Sloane PJ, Gee MH, Gottlieb JE, Alberzine KH, Peters SP, Burns JR, Machiedo G, Fish JE. A multicenter registry of patients with acute respiratory distress syndrome: physiology and outcome. Am Rev Respir Dis 1992;146:419-26.
16. Moss M, Goodman PL, Heinig M, Barkin S, Ackerson L, Parsons PE. Establishing the relative accuracy of three new definitions of the adult respiratory distress syndrome. Crit Care Med 1995;23:1629-37.
17. DiRusso SM, Nelson LD, Safcsak K, Miller RS. Survival in patients with severe adult respiratory distress syndrome treated with high-level positive and expiratory pressure. Crit Care Med 1995;23:1485-96.
18. Springer RR, Stevens PM. The influence of PEEP on survival of patients in respiratory failure. Am J Med 1976;66:196-200.
19. Dreyfuss D, Saumon G. Should the lung be rested or recruited?: the charybdis and scylla of ventilator management. Am J Respir Crit Care Med 1994;149:1066-8.
20. Morris AH. Adult respiratory distress syndrome and new modes of mechanical ventilation: reducing the complications of high volume and high pressure. New Horizons 1994;2:219-33.
21. Gluck E, Heard S, Patel C, Mohr J, Calkins J. Use of ultra high frequency ventilation in patients with ARDS: a preliminary report. Chest 1993;103:1413-20.
22. Shanholtz C, Brower R. Should inverse ratio ventilation be used in adult respiratory distress syndrome? Am J Respir Crit Care Med 1994;149:1354-8.
23. Reynolds AM, Ryan DP, Doody DP. Permissive hypercapnia and pressure-controlled ventilation as treatment of severe adult respiratory distress syndrome in a pediatric burn patient. Crit Care Med 1993;21:468-72.
24. Gilston A. ARDS: another approach? Intensive Crit Care Dig 1985;4:1-2.
25. Suchyta MR, Clemmer TP, Orme JF, Morris AH, Elliott CG. Increased survival of ARDS patients with severe hypoxemia (ECMO criteria). Chest 1991;99:951-5.
26. Matthay M. New modes of mechanical ventilation for ARDS: how should they be evaluated? Chest 1989;95:1175-6.
27. Brandstetter RD. Ventilators back to the future. Chest 1994;105:983-4.
28. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High dose corticosteroids in patients with the adult respiratory syndrome. N Engl J Med 1987;317:1565-70.
29. Meduri GU, Chinn AJ, Leeper KV, Wunderink RG, Tolley E, Winer-Muram HT, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest 1994;105:1516-27.
30. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 1995;107:1062-73.
31. Parsons PE, Moore FA, Moore EE, Ikle DN, Henson PM, Worthen GS. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 1992;146:694-700.
32. St. John RC, Dorinsky PM. Immunologic therapy for ARDS, septic shock, and multiple-organ failure. Chest 1993;103:932-43.
33. Palmer RMJ, Ashton DS, Doncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
34. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
35. Rossaint R, Gerlach H, Schmidt-Ruhnke H, Pappert D, Lewandowski K, Stendel W, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995;107:1107-15.
36. Broaddus VC, Berthiaume Y, Biondi JW, Matthay MA. Hemodynamic management of the adult respiratory distress syndrome. J Intensive Care Med 1987;2:190-213.
37. Schuster DP. The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome. New Horizons 1993;1:478-88.
38. Wheeler AP, Carroll FE, Bernard GR. Radiographic issues in adult respiratory distress syndrome. New Horizons 1993;1:471-7.
39. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, et al. Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med 1983;98:593-7.
40. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982;144:124-30.
41. Heffner JE, Brown LK, Barbieri CA, Harpel KS, Deleo J. Prospective validation of an acute respiratory distress syndrome predictive score. Am J Respir Care Med 1995;152:1518-26.
42. Montgomery AB, Stoger MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-9.
43. Hyers TM. Prediction of survival and mortality in patients with adult respiratory distress syndrome. New Horizons 1993;1:466-70.
44. Jenkinson SG. Oxygen toxicity. New Horizons 1993;1:504-11.
45. Russell JA, Phang PT The oxygen delivery consumption controversy: approaches to management of the critically ill. Am J Respir Crit Care Med 1994;149:537-53.
46. Wheeler AP. Sedation, analgesia, and paralysis in the intensive care unit. Chest 1993;104:566-76.
47. Andreadis N, Petty TL. Adult respiratory distress syndrome: problems and progress. Am Rev Respir Dis 1985;132:1344-6.
48. Brandstetter RD. The adult respiratory distress syndrome 1986. Heart Lung 1985;15:155-64.
49. Chapman MJ. Adult respiratory distress syndrome: an update. Anaesth Intens Care 1994;22:255-66.
50. Fulkerson WJ, McIntyre N, Stamler J, Crapo JD. Pathogenesis and treatment of the adult respiratory distress syndrome. Arch Intern Med 1996;156:29-40.
51. Goldsberry DT, Hurst JM. ARDS and sepsis. New Horizons 1993;1:342-7.
52. Bone RC, Slotman G, Maunder R, Silverman H, Hyers TM, Kerstein MD, Randomized double-blind, multicenter study of prostaglandin E in patients with the adult respiratory distress syndrome. Chest 1989;96:114-9.
53. McHugh LG, Milberg JA, Whitcomb ME, Schoene RB, Maunder RJ, Hudson LD. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:90-4.
54. Suter PM, Domenighetti G, Schaller MD, Laverriere MC, Ritz R, Perret C. N-acetylcysteine enhances recovery from acute lung injury in man. Chest 1994;105:190-4.
55. Pepe PE. The clinical entity of adult respiratory distress syndrome: definition, prediction, and prognosis. Crit Care Clin 1986;2:377-97.
56. Demling RH. The role of mediators in human ARDS. J Crit Care 1988;3:56-72.
57. Pinsky M, Matuschak G. A unifying hypothesis of multiple systems organ failure: failure of host defense homeostasis. J Crit Care 1990;5:108-14.
58. 2 formation is increased in human sepsis syndrome. Am Rev Respir Dis 1991;144:1095-101.
59. Shapiro L, Gelfand J. Cytokines and sepsis: pathophysiology and therapy. New Horizons 1993;1:13-22.
60. Duchateau J, Haas M, Schreyen H, Radoux L, Sprangers I, Noel FX, et al. Complement activation in patients at risk of developing the adult respiratory distress syndrome. Am Rev Respir Dis 1984;130:1058-64.
61. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
62. Prielipp RC, Coursin DB. Applied pharmacology of common neuromuscular blocking agents in critical care. New Horizons 1994;2:34-47.
63. Gooch JL, Suchyata MR, Balbierz JM, Petajan JH, Clemmer TP. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991;19:1125-30.
64. Gionnoti L, Alexander JW, Nelson JL, Fukushima R, Pules T, Chalk CL. Role of early enterai feeding and acute starvation on postburn bacterial translocation and host defense: prospective, randomized trials. Crit Care Med 1994;22:265-72.
65. East T. The magic bullets in the war on ARDS: aggressive therapy for oxygenation failure. Respir Care 1993;38:690-702.
66. Fulkerson WJ, Maclntyre N, Stamler J, Crapo JD. Pathogenesis and treatment of the adult respiratory distress syndrome. Arch intern Med 1996;156:29-38.
67. Zapol WM. Volotrauma and the intravenous oxygenator in patients with adult respiratory distress syndrome. Anesthesiology 1992;77:847-9.
68. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137:1159-64.
69. Coghill CH, Haywood JL, Chatburn RL. Neonatal and pediatric high-frequency ventilation: principles and practice. Resp Care 1991;36:596-612.
70. O'Rouke PP, Crone PK, Vacanti JP, Ware JH, Lillehei CW, Parad RB, et al. A prospective randomized study of extra corporeal membrane oxygenation (ECMO) and conventional medical therapy in neonate with persistent preliminary hypertension of the newborn. Pediatrics 1989;84:957-63.
71. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL. Effects of N-Acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin invest 1984;73:1772-84.
72. Wiedemann H, Baughman R, DeBoisblanc B. Multicenter trial in human sepsis-induced ARDS of an aerosolized synthetic surfactant (Exosurf®) [abstract]. Am Rev Respir Dis 1992;145:A184.
73. Walmrath D, Schneider T, Pelch R, Grimminger F, Seeger W. Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 1993;342:961-2.
74. Yu M, Tomasa G. A double blind, prospective, randomized trial of Ketoconazole, a thromboxane A2 inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993;21:1635-42.
75. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47.
76. Pappert D, Rossaint R, Lopez F Prone position in severe ARDS influences ventilation/perfusion relationship of the lung [abstract]. Intern Care Med 1992;18(Suppl 2):A16.
77. Baumann WR, Jung RC, Koss M, Borlen CT, Navarro L, Sharma OP Incidence and mortality of adult respiratory distress syndrome: a prospective analysis from a large metropolitan hospital. Crit Care Med 1986;14:1-4.
78. Gee MH, Gottlieb JE, Albertine KH, Kubis JM, Peters SP, Fish JE. Physiology of aging related to outcome in the adult respiratory distress syndrome. J Appl Physiol 1990;60:822-9.
79. Maunder RJ, Kublis PS, Anardi DM. Determinants of survival in the adult respiratory distress syndrome (ARDS) [abstract]. Am Rev Respir Dis 1989;139:A220.
80. Bell RC, Coalson JJ, Smith JD, Johanson WG, Jr. Multiple organ system failure and infection in the adult respiratory distress syndrome. Ann Intern Med 1983;99:293-8.
81. Bone RC, Balk R, Slotman G, Maunder R, Silverman H, Hyers TM. Adult respiratory distress syndrome: sequence and importance of development of multiple organ failure. Chest 1992;101:320-6.
82. Cox SC, Norwood SH, Duncan CA. Acute respiratory failure: mortality associated with underlying disease. Crit Care Med 1985;13:1005-8.
83. Ingbar DH, Matthay RA. Pulmonary sequelae and lung repair in survivors of the adult respiratory distress syndrome. Crit Care Clin 1986;2:629-65.
84. Downs JB, Olsen GN. Pulmonary function following adult respiratory distress syndrome. Chest 1974;65:92-3.